DrugPatentWatch Database Preview
Merlion Pharms Gmbh Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for MERLION PHARMS GMBH, and when can generic versions of MERLION PHARMS GMBH drugs launch?
MERLION PHARMS GMBH has one approved drug.
There are three US patents protecting MERLION PHARMS GMBH drugs.
There are forty patent family members on MERLION PHARMS GMBH drugs in eighteen countries.
Summary for Merlion Pharms Gmbh
| International Patents: | 40 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Merlion Pharms Gmbh
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | 9,504,691 | Start Trial | Y | Start Trial | |||
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | 8,536,167 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Merlion Pharms Gmbh
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | 6,133,260 | Start Trial |
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | 6,432,948 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Merlion Pharms Gmbh Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Uruguay | 32758 | Start Trial |
| Japan | 5784012 | Start Trial |
| Chile | 2011003327 | Start Trial |
| Canada | 2765852 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
